Multiple sclerosis treatment underutilization predicts high risk for obstructive sleep apnea in patients with multiple sclerosis

被引:2
作者
Dempsey, John Patrick [1 ,2 ]
Balshi, Alexandra [1 ]
Bouley, Andrew [3 ]
Egnor, Emily [4 ]
Samaan, Soleil [1 ]
Baber, Ursela [1 ]
Sloane, Jacob A. [1 ]
机构
[1] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA
[2] SUNY, Norton Coll Med, Upstate Med Univ, Syracuse, NY USA
[3] Elliot Lewis Ctr Multiple Sclerosis Care, Wellesley, MA USA
[4] Univ Miami, Leonard M Miller Sch Med, Miami, FL USA
关键词
Obstructive sleep apnea; Disease-modifying therapies; Medication possession ratio; FATIGUE; QUESTIONNAIRE; DISORDERS; SEVERITY; AROUSAL;
D O I
10.1016/j.msard.2024.105889
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Obstructive sleep apnea (OSA) is more common in patients with multiple sclerosis (MS) than in the general population, which suggests MS may predispose patients to OSA. However, the relationships between MS treatment, disease activity, disease severity, fatigue, and OSA are unknown. Objectives: To evaluate the connections between OSA risk, MS fatigue, and MS severity, controlling for wellestablished risk factors for OSA in the general population. Methods: We administered OSA and fatigue-related questionnaires to patients with MS and collected relevant demographic and clinical data. Then, we utilized multivariate logistic regression to examine relationships between OSA risk and MS disease severity. Results: We identified an inverse correlation between medication possession ratio (MPR) and high OSA risk. Statistical models also demonstrated a positive correlation between fatigue and nonwhite race with high OSA risk, controlling for male sex, younger age, and body mass index (BMI). Conclusion: We identified disease-modifying therapy (DMT) underutilization, fatigue, and nonwhite race as predictors of high OSA risk in patients with MS. These findings support aggressive treatment of MS to avoid risk of comorbid OSA and MS-induced fatigue.
引用
收藏
页数:5
相关论文
共 50 条
[41]   Daclizumab in treatment of multiple sclerosis patients [J].
Ali, E. N. ;
Healy, B. C. ;
Stazzone, L. A. ;
Brown, B. A. ;
Weiner, H. L. ;
Khoury, S. J. .
MULTIPLE SCLEROSIS JOURNAL, 2009, 15 (02) :272-274
[42]   Insufficient sleep: another risk factor for multiple sclerosis [J].
Aoun, Raissa ;
Attarian, Hrayr ;
Graham, Edith .
SLEEP, 2024, 47 (10)
[43]   Sleep disturbances in multiple sclerosis [J].
Caminero, Ana ;
Bartolome, Manuel .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2011, 309 (1-2) :86-91
[44]   Sleep Abnormalities in Multiple Sclerosis [J].
Giorgos K. Sakkas ;
Christoforos D. Giannaki ;
Christina Karatzaferi ;
Mauro Manconi .
Current Treatment Options in Neurology, 2019, 21
[45]   Sleep and fatigue in multiple sclerosis [J].
Stanton, B. R. ;
Barnes, F. ;
Silber, E. .
MULTIPLE SCLEROSIS JOURNAL, 2006, 12 (04) :481-486
[46]   Sleep Abnormalities in Multiple Sclerosis [J].
Sakkas, Giorgos K. ;
Giannaki, Christoforos D. ;
Karatzaferi, Christina ;
Manconi, Mauro .
CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2019, 21 (01)
[47]   Prevalence of Poor Sleep Quality and Sleep Disturbances in Icelanders with Multiple Sclerosis [J].
Albertsdottir, Adalbjorg ;
Sigurdardottir, Arun K. ;
Thorleifsdottir, Bjorg .
LAEKNABLADID, 2019, 105 (09) :379-384
[48]   The multiple challenges of obstructive sleep apnea in children: morbidity and treatment [J].
Gozal, David ;
Kheirandish-Gozal, Leila .
CURRENT OPINION IN PEDIATRICS, 2008, 20 (06) :654-658
[49]   Impact of sleep disorder treatment on fatigue in multiple sclerosis [J].
Cote, I. ;
Trojan, D. A. ;
Kaminska, M. ;
Cardoso, M. ;
Benedetti, A. ;
Weiss, D. ;
Robinson, A. ;
Bar-Or, A. ;
Lapierre, Y. ;
Kimoff, R. J. .
MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (04) :480-489
[50]   Interdisciplinary Risk Management in the Treatment of Multiple Sclerosis [J].
Havla, Joachim ;
Warnke, Clemens ;
Derfuss, Tobias ;
Kappos, Ludwig ;
Hartung, Hans-Peter ;
Hohlfeld, Reinhard .
DEUTSCHES ARZTEBLATT INTERNATIONAL, 2016, 113 (51-52) :879-+